Is there a method to determine fake urine was used in a urinalysis?
Our lab partners use the most advanced screening technology, including screening methods to detect synthetic urine, to ensure quality control measures are in place for donors who try and cheat on a drug test. For more information on fake urine products and their effects on drug tests, read our fake urine blog here: https://disa.com/blog/fake-urine-and-drug-test-abuse
It is said that you would have to take CBD in 1000-2000mg doses for it to show up on a test and the fact that THC products are not regulated, and the dosing could be off. Is that true for everyone, or do some clients get to decide their threshold?
There is no test for CBD, DISA’s tests will screen for THC or cannabinoids. Any test that screens for THC or cannabinoids is going to report findings for THC or cannabinoids that exceed the panel thresholds (levels). The origin of the substance will not be considered by the Medical Review Officer (MRO). DISA’s non-DOT corporate policy offers clients the option to customize testing panels.
How can an employer apply for the FMCSA Under-21 Non-Military Pilot Program?
"Currently, 49 states and the District of Columbia already allow 18 to 20-year-old CDL holders to operate CMVs in intrastate commerce—meaning under-21 drivers may currently drive within state borders, such as from Houston to El Paso or from Miami to Tallahassee." Additionally, the FMCSA proposed a new under-21 commercial driver pilot program for interstate commerce in 2020 that is still pending "thoughts and opinions". More information can be found on the FMCSA Proposed Pilot Program page. A similar program was launched for military members in 2018 and was proposed two years earlier before officially launching.
What is FormFox?
DISA partners with FormFox, the nation’s leading provider of Electronic Custody and Control Forms (eCCF) and electronic workflow solutions, to provide integrated solutions for workplace drugs of abuse testing and occupational health services. As a result, common collector errors and omissions are avoided, while also shortening the entire drug testing cycle by instantaneously delivering the electronic CCF and related data to key stakeholders like the MRO, TPA, Employer and Lab.